Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT04157192
ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients
ACU-BRAIN — Brain Connectome for … Migraine Non applicable COMPLETED En attente / non publié Centre Hospitalier Universitaire … France · CHU de Nîmes, Nîmes, France 2022-05-27 → 2025-04-24 Ouvrir
NCT07667621
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants…
Rimegepant Migraine Phase 1 NOT_YET_RECRUITING En attente / non publié University of South Florida United States · Tampa General Hospital Emergency Room… 2026-07 → 2027-08 Ouvrir
NCT06098755
The Sequestration of Holistic Stress Management Techniques for Adults
The Sequestration of Holistic Str… Migraine Non applicable WITHDRAWN En attente / non publié Goddess Zena I. Jones United States · Virtual Tribunal Monastery, Anchorage… 2026-01-26 → 2028-12 Ouvrir
NCT07021859
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related P…
Calcitonin-gene related peptide (… Migraine Non applicable RECRUITING En attente / non publié Danish Headache Center Denmark · Rigshospitalet Glostrup, Glostrup Municipal… 2025-06-27 → 2026-12-30 Ouvrir
NCT05987592
BE WELL With Migraine: Brain Education and WELLness With Migraine
BE WELL With Migraine: Brain Educ… Migraine Non applicable RECRUITING En attente / non publié Wake Forest University Health Sci… United States · Cambridge Health Alliance - Center fo… 2024-07-31 → 2027-12-31 Ouvrir
NCT06695156
Exploring the Effect of the Transcendental Meditation® Technique on Mig…
Exploring the Effect of the Trans… Migraine Non applicable COMPLETED En attente / non publié Maharishi International University United States · Georgetown Headache Center and DC are… 2024-08-28 → 2026-05-30 Ouvrir
NCT05207865
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Mi…
Rimegepant Migraine Phase 4 COMPLETED En attente / non publié University of South Florida United States · Advanced Investigative Medicine, Inc.… 2022-03-15 → 2024-07-02 Ouvrir
NCT05616741
BioCer — Home-based Biofeedback for the Prevention of Migraine
Cerebri biofeedback Migraine Non applicable COMPLETED En attente / non publié Nordic Brain Tech AS Norway · Akershus University Hospital HF, Lørenskog, … 2023-01-01 → 2024-09-23 Ouvrir
NCT05943457
ViKEM — Vitamin K2 Supplementation in Adult Episodic Migraine
ViKEM — Vitamin K2 Supplementatio… Migraine Non applicable RECRUITING En attente / non publié Sola Aoun Bahous, M.D. Ph.D. Lebanon · Lebanese American University Medical Center… 2024-03-06 → 2026-12 Ouvrir
NCT07072910
PROTECT — Cabergoline for Episodic Migraine
Cabergoline 0.5 MG Migraine Phase 2 RECRUITING En attente / non publié Aarhus University Hospital Denmark · Aarhus University Hospital, Aarhus N, Denma… 2025-11-12 → 2028-09-01 Ouvrir
NCT07268768
AURA — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSIT…
AURA — PERSONOLOGICAL STRUCTURE, … Migraine À vérifier RECRUITING En attente / non publié IRCCS Centro Neurolesi Bonino Pul… Italy · Irccs Centro Neurolesi Bonino Pulejo, Messina… 2025-11-20 → 2028-11-20 Ouvrir
NCT05028569
Study of BOTOX Injections in Prevention of Migraine in Adult Participan…
BOTOX Migraine Phase 3 TERMINATED En attente / non publié AbbVie United States, Canada, Czechia, Germany, Israel, Pola… 2021-11-05 → 2024-11-06 Ouvrir
NCT07279623
A-MI-01 — Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Pr…
INMEST-treatment Migraine Non applicable RECRUITING En attente / non publié Abilion Medical Systems AB Sweden · INMEST-mottagningen Odenplan, Stockholm, Swe… 2025-10-21 → 2026-09 Ouvrir
NCT05217927
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention…
Rimegepant 75mg daily dosing Migraine Phase 4 COMPLETED En attente / non publié Pfizer United States, Austria, Canada, France, Germany, Ital… 2022-03-04 → 2024-12-11 Ouvrir
NCT04686136
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepan…
Atogepant 60 mg Migraine Phase 3 COMPLETED En attente / non publié Fundación de Investigación Bioméd… United States, Canada, Czechia, Denmark, France, Germ… 2021-02-19 → 2025-10-20 Ouvrir
NCT03432286
REBUILD-1 — A Study of Galcanezumab (LY2951742) in Participants 6 to 17…
Galcanezumab Migraine Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Eli Lilly and Company United States, Denmark, Germany, India, Italy, Japan,… 2018-03-14 → 2026-11 Ouvrir
NCT07313800
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Em…
TEMMA Endovascular Treatment Migraine Non applicable NOT_YET_RECRUITING En attente / non publié Cortex Neurovascular United States · Cortex Neurovascular / TRA Union, Tac… 2026-03-01 → 2028-03-01 Ouvrir
NCT03461874
ACTMigraine — ACT Therapy for HF Migraine
Pharmacological prophylaxis Migraine Non applicable COMPLETED En attente / non publié Fondazione I.R.C.C.S. Istituto Ne… Italy · Fondazione IRCCS Istituto Neurologico C. Best… 2018-03-15 → 2022-12-31 Ouvrir
NCT05003362
ACT for High Frequency Migraine; A Virtual Mindfulness Intervention
ACT for High Frequency Migraine; … Migraine Non applicable COMPLETED En attente / non publié Brigham and Women's Hospital United States · Brigham and Womens Hospital, Boston, … 2020-10-25 → 2021-11-23 Ouvrir
NCT04252742
EMBRACE — Erenumab - Comprehensive Assessment of Efficacy in (High-Freq…
Erenumab Migraine Phase 4 COMPLETED En attente / non publié Amgen United States, Bulgaria, Czechia, Hungary, Italy, Pol… 2020-09-15 → 2023-10-26 Ouvrir
NCT07508449
EXEMIG/01 — EXErcise in MIGraine
EXEMIG/01 — EXErcise in MIGraine Migraine Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Centro Universitario Ricerca Inte… Italy · Centro Cefalee c/o Ospedale Santa Maria della… 2025-02-03 → 2027-02-03 Ouvrir
NCT06617832
Trial Designs for Evaluating Migraine Treatment
Active drug for acute migraine tr… Migraine Non applicable RECRUITING En attente / non publié University of Aarhus Denmark · Department of Neurology, Aarhus University … 2024-11-13 → 2028-09 Ouvrir
NCT07559565
MechSens_Migra — Migraine is Associated With Altered Mechanical Pain Se…
MechSens_Migra — Migraine is Asso… Migraine À vérifier NOT_YET_RECRUITING En attente / non publié Bernhard Taxer Austria · Universitätsklinik für Neurologie, neurolog… 2026-06-01 → 2026-11-30 Ouvrir
NCT07496034
GTSEM — Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migrai…
Gou-Teng-San Migraine Phase 3 RECRUITING En attente / non publié Tsai, Chueh-Yi, MD Taiwan · Chung Shan Medical University Hospital, Taic… 2025-07-01 → 2026-12-31 Ouvrir
NCT05861427
JPN PIVOTAL — Study of Oral Atogepant Tablets to Assess Change in Disea…
Atogepant Migraine Phase 3 COMPLETED En attente / non publié AbbVie Japan · Atago Hospital /ID# 245818, Kochi, Japan | Ch… 2023-07-12 → 2025-03-01 Ouvrir